AXGN Stock Analysis: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
$50.40
3.96 (8.53%)
▲
5d:
+3.43%
30d:
+26.86%
90d:
+22.0%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AXGN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AXGN shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.66
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$20.90
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AXGN is currently trading at $50.40, which is considered extended relative to its 30-day fair value range of $39.86 to $48.01. From a valuation perspective, the stock is trading at a premium (Forward PE: 72.9) compared to its historical average (57.2). At these levels, the market is pricing in 8.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $51.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.5% recently.
Market Sentiment: AXGN scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $51.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.5% recently.
Market Sentiment: AXGN scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$39.86 -
$48.01
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
27.6%
Protect Your Profits
Holding AXGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (10/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.5%)
- NEUTRAL: Near Wall St target ($53.22)
- NEUTRAL: Trading at premium valuation - market expects 8.4% growth which is achievable
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$39.86 -
$48.01
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$45.26
Resistance Level
$51.06
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
72.90
Wall Street Target
$53.22
(+5.6%)
Revenue Growth (YoY)
23.1%
Profit Margin
-13.4%
Valuation Premium vs History
+8.4% premium
PE vs Historical
72.9 vs 57.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.4%
(market-implied from PE analysis)
1-Year Target
$54.63
(+8%)
2-Year Target
$59.22
(+18%)
3-Year Target
$64.20
(+27%)
3-Yr Target (if PE normalizes)
(PE: 73→57)
PE COMPRESSION
$50.37
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 72.9, Growth: 50.9%)
$170.10
(+238%)
Base:
(SPY PE: 20.1, Growth: 50.9%)
$46.83
(-7%)
Bear:
(PE: 17.1, Growth: 50.9%)
$39.81
(-21%)
Share & Embed Analysis
Last updated: August 22, 2026 6:35 PM ET
Data refreshes hourly during market hours. Next update: 7:35 PM
Data refreshes hourly during market hours. Next update: 7:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AXGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Erick Wayne Devinney
SELL
5221 shares
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 35 SELL |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.
